Back to Newsroom

Alder BioPharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

BOTHELL, Wash., September 9, 2015 – Alder BioPharmaceuticals, Inc. (“Alder”) (NASDAQ: ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, autoimmune and inflammatory diseases, today announced that Randall C. Schatzman, Ph.D., President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2015 at 9:55 a.m. ET in New York, NY.

Click here to read more